Healos

Healos

Orthopedics A fully resorbable, sponge-like matrix of collagen mineralized with resorbable hydroxyapatite to promote bone healing, as an alternative to autologous bone graft; Healos is a bioactive scaffold that mimics bone's biochemical and architectural properties. See Bone graft.
Mentioned in ?
References in periodicals archive ?
Switzerland-based Auris Medical has completed patient enrolment in the Phase three HEALOS clinical trial of its AM-111, in idiopathic sudden sensorineural hearing loss (ISSNHL), also called sudden deafness, it was reported yesterday.
Under first HEALOS trial, which is being conducted in several European and Asian countries, the company aims to enroll approximately 255 patients with severe to profound idiopathic sudden sensorineural hearing loss.
Vitoss (B-TCP: OrthoVita, Malvern PA, USA) and Healos (DePuy Orthopaedics, Inc.
Healos (DePuy Orthopaedics, Inc, Warsaw, Ind) is a natural polymer-based product, a polymerceramic composite consisting of collagen fibers coated with hydroxyapatite and indicated for spinal fusions (195).
HEALOS Fx is a moldable, injectable version of HEALOS[R] Bone Graft Replacement, which is the company's osteoconductive and osteogenic (when combined with bone marrowaspirate) bone graft substitute, shown to achieve fusion rates equivalent to autograft in peer-reviewed, published human clinical studies.
Another osteoconductive material that is sometimes mixed with aspirated cell is Healos (DePuy Johnson and Johnson, Raynam, Mass).
Cow print, pounds 20, rainbow hottie, pounds 9, HealOs, 020 7636 1666, www.
The biological and structural properties of Healos are ideal for use with GDF-5 for promoting new bone growth.
Auris Medical, a company that develops novel pharmaceutical therapies to protect hearing and to silence tinnitus, has enrolled the first patient into the pivotal HEALOS clinical trial with AM-111.
Healos has received CE Mark clearance in Europe for use as a replacement for bone material which is normally harvested from the patient's hip.
We are especially pleased to have Greg on board as we prepare for the European launch of Healos, the first bone grafting product shown to fully replace autograft in spinal fusion procedures.